METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA
Clinical trials for METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Virus therapy trial offers new hope for Tough-to-Treat lung cancer
Disease control Recruiting nowThis study is testing a new two-step treatment for advanced non-small cell lung cancer that has started to grow again after initial therapy. One group receives an intravenous modified virus designed to attack cancer cells, followed by standard chemotherapy and immunotherapy. The …
Matched conditions: METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New combo therapy aims to keep advanced lung cancer in check
Disease control Recruiting nowThis study is testing whether adding the drug cabozantinib to pembrolizumab can help control advanced squamous non-small cell lung cancer for longer. It is for patients whose cancer has not worsened after an initial 4-cycle treatment. The main goal is to see how long patients can…
Matched conditions: METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC